GSK-945237

DB15345InvestigationalSmall molecule

GSK-945237 is under investigation in clinical trial NCT01039610 (A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose...

Formula / weight: C₂₄H₂₆FN₅O₃ · 451.502 g/mol (avg)
Code names: GSK-945237

Resolves to

Compound

UNIIU9T63BZ3ASCAS944406-54-6ChEMBLCHEMBL3793226

Structure

InChIKeySRICOHRDRMZREQ-MRXNPFEDSA-NSMILESFC1=C2[C@H](CN3CCC(CC3)NCC3=NN=C4OCCOC4=C3)CN3C2=C(C=C1)C=CC3=O

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of GSK-945237, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account